drugset / Trial / NCT05480592
A Study of HS-10380 in Chinese Participants
RandomizedSequentialQuadruple-blindTreatment
Summary
The primary objective of this study is to assess the safety and tolerability of single and multiple oral administered doses of HS-10380 in Chinese healthy subjects.
Timeline
- Start
- 2022-08-01
- Primary completion
- 2023-06-30
- Completion
- 2023-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HS-10380 | Unknown | — | Oral |